NanoViricides' NV-387 Near FDA Approval, LivingPhoenix Unveils Collagen Breakthrough, Octopus Arms Drive Robotics Innovation, Scientists Win Lasker Award, and more...

brief.news

12 September 2025

(0:10): NanoViricides' NV-387 Antiviral Advances Toward FDA Approval, Promises Billions in Stockpiling Contracts(2:41): LivingPhoenix's POGMENT Collagen Revolutionizes Bioengineering with Major Scientific Recognition and Global Expansion(5:09): Octopus Arms Inspire Next-Gen Robotics with Their Flexibility and Precision(7:10): Scientists Win 2025 Lasker Award for Breakthrough Cystic Fibrosis Therapy Trikafta(9:29): Revolutionary MRI Method Could Transform Prostate Cancer Screening with Faster, Cheaper, and Safer ScansTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: EurekAlert!